1. Home
  2. ABEO vs AZ Comparison

ABEO vs AZ Comparison

Compare ABEO & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • AZ
  • Stock Information
  • Founded
  • ABEO 1974
  • AZ 2018
  • Country
  • ABEO United States
  • AZ Canada
  • Employees
  • ABEO N/A
  • AZ N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • AZ Industrial Machinery/Components
  • Sector
  • ABEO Health Care
  • AZ Industrials
  • Exchange
  • ABEO Nasdaq
  • AZ Nasdaq
  • Market Cap
  • ABEO 289.2M
  • AZ 319.5M
  • IPO Year
  • ABEO 1980
  • AZ N/A
  • Fundamental
  • Price
  • ABEO $5.26
  • AZ $7.48
  • Analyst Decision
  • ABEO Strong Buy
  • AZ Strong Buy
  • Analyst Count
  • ABEO 6
  • AZ 1
  • Target Price
  • ABEO $18.17
  • AZ $20.00
  • AVG Volume (30 Days)
  • ABEO 1.1M
  • AZ 448.1K
  • Earning Date
  • ABEO 11-13-2025
  • AZ 11-12-2025
  • Dividend Yield
  • ABEO N/A
  • AZ N/A
  • EPS Growth
  • ABEO N/A
  • AZ N/A
  • EPS
  • ABEO 0.99
  • AZ N/A
  • Revenue
  • ABEO $400,000.00
  • AZ $7,489,000.00
  • Revenue This Year
  • ABEO N/A
  • AZ $1,343,857.60
  • Revenue Next Year
  • ABEO $324.71
  • AZ N/A
  • P/E Ratio
  • ABEO $5.31
  • AZ N/A
  • Revenue Growth
  • ABEO N/A
  • AZ 19.04
  • 52 Week Low
  • ABEO $3.93
  • AZ $1.76
  • 52 Week High
  • ABEO $7.54
  • AZ $12.36
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 31.86
  • AZ 33.71
  • Support Level
  • ABEO $5.19
  • AZ $7.35
  • Resistance Level
  • ABEO $5.49
  • AZ $7.93
  • Average True Range (ATR)
  • ABEO 0.19
  • AZ 0.52
  • MACD
  • ABEO 0.01
  • AZ -0.04
  • Stochastic Oscillator
  • ABEO 12.84
  • AZ 2.86

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About AZ A2Z Smart Technologies Corp.

A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.

Share on Social Networks: